Scarica l'app Stockscreener
28.76
0.03%
-0.1367
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Enterprise value to EBITDA forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences Inc: Plans to Initiate a - Moomoo
ASMBAssembly Biosciences Inc Options - Finviz
Discipline and Rules-Based Execution in ASMB Response - Stock Traders Daily
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS:ASMB) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2500 Value Benchmark - marketscreener.com
Health Care had the best week vs. the S&P 500 on record (XLV:NYSEARCA) - Seeking Alpha
Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB) - TradingView
Assembly Biosciences, Inc. Actuals & Estimates (TRADEGATE:V7B) - TradingView
ASMB Forecast — Price Target — Prediction for 2027 - TradingView
Assembly Biosciences Inc (ASMB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Institutional Confidence - TradingKey
Behavioral Patterns of ASMB and Institutional Flows - Stock Traders Daily
Assembly Biosciences (ASMB) PFO sells 29 shares to cover RSU taxes - Stock Titan
Assembly Biosciences Inc (ASMB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Assembly Biosciences Inc (ASMB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Assembly Biosciences Inc (ASMB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ASMB Maintained by Mizuho -- Price Target Raised to $45 - GuruFocus
Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating - Moomoo
Assembly Biosciences eyes Gilead HSV plan as ABI-6250 liver pipeline expands - MSN
ASMB SEC FilingsAssembly Bioscie 10-K, 10-Q, 8-K Forms - Stock Titan
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead - MarketBeat
(ASMB) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Assembly Biosciences Expands Equity Plans, Reelects Board - TipRanks
Assembly Biosciences (ASMB) CMO awarded 14,000-share RSU-based stock grant - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison - Stock Titan
Assembly Biosciences (ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) director receives 8,000 stock options grant - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (NASDAQ: ASMB) receives 8,000 options - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) PFO awarded 3,500 RSUs - Stock Titan
Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment - Stock Titan
Assembly Biosciences (ASMB) CEO receives 50,750 RSUs in equity grant - Stock Titan
Assembly Biosciences (ASMB) shareholders back directors, equity plan and ESPP share hikes - Stock Titan
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - Yahoo Finance
Assembly Biosciences synthesizes new anti-cytomegalovirus agents - BioWorld News
Gilead Sciences, Inc. Acquires Significant Stake in Assembly Biosciences Inc. - GuruFocus
Gilead Sciences, Inc. Acquires Significant Stake in Assembly Bio - GuruFocus
Assembly Biosciences Announces Upcoming Investor Conference Presentations - The Manila Times
ASMB Reiterated by Guggenheim -- Price Target Maintained at $43 - GuruFocus
Biotech Assembly Bio set for June Jefferies, Goldman investor chats - Stock Titan
Assembly Biosciences (ASMB) Holds Steady Near Resistance as Biotech Sector WatchesSector ETF Flow - The Legal Advocate
How (ASMB) Movements Inform Risk Allocation Models - Stock Traders Daily
Gilead boosts Assembly Biosciences (NASDAQ: ASMB) ownership to 25.1% of shares - Stock Titan
Gilead adds Assembly Biosciences (ASMB) shares through new stock grant - Stock Titan
Assembly Biosciences (ASMB) Declines 4.7% as Stock Tests Key Support Near $26PCR Moving Average - newsline.com
Assembly Biosciences closes $115 million stock offering - Investing.com UK
Assembly Biosciences closes $115 million stock offering By Investing.com - Investing.com South Africa
1.21%
3.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):